Longitude Capital portfolio
Longitude Capital (Venture capital) is known to hold 79 companies, 26 of them startups. 21 of them are hiring now, with 735 open roles. Its companies closed 6 venture rounds in 12 months, raising $201.4M. Most of them work in Biologics & Biosimilars, Oncology Therapeutics, Drug Discovery.
Companies Longitude Capital has invested in
Open roles at Longitude Capital portfolio companies
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about Longitude Capital
How many companies has Longitude Capital invested in?
Longitude Capital is known to hold 79 companies: 26 startups, and 27 exits so far, read from its own portfolio page and the funding rounds that name it.
Is Longitude Capital investing now?
Longitude Capital has no round in the press in 12 months and no new company on its portfolio page in 90 days.
What does Longitude Capital invest in?
The markets of the companies Longitude Capital holds: Biologics & Biosimilars (10%), Oncology Therapeutics (6%), Drug Discovery (5%), Prescription Drugs (5%), Health & Medical Electronics (5%).
Which Longitude Capital portfolio companies are hiring?
21 companies Longitude Capital holds are hiring now, with 735 open roles listed on this page.
Who does Longitude Capital invest alongside?
The investors that hold the most companies together with Longitude Capital: RA Capital Management, NEA, OrbiMed, Sofinnova Investments, Endeavour Vision.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 3
Longitude Capital portfolio: 79 known companies. Alion, Oct 21, 2026. https://alion.io/company/longitude-capital/portfolio
